FDA & Prescription Drugs
Vioxx: New Insight On The VIGOR Study
Did Merck & Co. act appropriately back in 1999 when it discovered the dangers of heart attack and stroke associated with its product Vioxx? A new article published in today’s NPR puts that question to the test by questioning three renown scientists who are authorities on heart disease and clinical s